“New investigators must to be offered the opportunities to communicate their work. They need to obtain the exposure and external visibility which could in turn prove very useful for them, in so many ways. The NIA offers a forum for promoting their career and conveying their ideas. It can be a constructive experience in every stage of the competition.
There are so many talented new investigators out there which makes me feel really excited to be part of this year’s panel and really looking forward to meeting this year’s nominees.”
Panagiotis Vorkas is a post-doctoral researcher at the Section of Computational and Systems Medicine of Imperial College London. He is focusing in bioanalysis with special interest in developing workflows for targeted and untargeted metabolic and lipid profiling in tissue, with the ultimate aim of expanding metabolome coverage. He is working under the theme of cardiovascular disease and risk factors. Guided by biomarker discovery approaches he is now elaborating on biomarker validation and elucidation of disease pathways.
Panos obtained a Bachelor degree in Chemistry in 2006 and a Masters in Clinical Chemistry in 2009. He was awarded a PhD in Biochemistry in August 2014. He has been working in the field of bioanalysis for about 10 years and is a past recipient of the Bioanalysis Zone New Investigator Award.